CoChat

Prospects for Rational Development of Pharmacological Gap Junction Channel Blockers

David C. Spray, Bentham Science Publisher, Renato Rozental, Bentham Science Publisher, Miduturu Srinivas, Bentham Science Publisher · 2002 · Current Drug Targets
Cited by 76

The DOI matches its Crossref record.

Abstract

Connexin-null mice and human genetic gap junction diseases illustrate the important roles that gap junction channels play under normal conditions, and the neuro- and cardioprotective effects of gap junction blocking agents demonstrate that closure of these channels may be beneficial in certain pathological situations. This overview summarizes studies in which gap junction modifying reagents have been characterized, highlighting examples of agents for which selectivity for gap junction subtypes has been demonstrated. In addition, strategies for targeting connexin domains through peptide inhibitors are outlined, which may ultimately provide agents that are not only connexin-selective in their actions, but also affect only a subset of a gap junction channel's gating responses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1389450023347353

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 76

Metadata

Authors
David C. Spray, B. S. P., Renato Rozental, B. S. P., & Miduturu Srinivas, B. S. P.
Venue
Current Drug Targets
Published
2002-12-01
Volume
3
Issue
6
Pages
455-464
ISSN
1389-4501 (ISSN-L)
OpenAlex
W2153921203
Cited by
76
References
0
FWCI
1.08
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prospects for Rational Development of Pharmacological Gap Junction Channel Blockers. https://app.cochat.ai/papers/10.2174/1389450023347353
The paper
David C. Spray, B. S. P., Renato Rozental, B. S. P., & Miduturu Srinivas, B. S. P. (2002). Prospects for Rational Development of Pharmacological Gap Junction Channel Blockers. Current Drug Targets. https://doi.org/10.2174/1389450023347353

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.